Significantly, low levels of tissue inhibitor of matrix metalloproteinase-3 (TIMP-3) protein expression in breast cancer has been reported to be correlated with an aggressive cancer phenotype [25]. This evidence concerns the gene TIMP3 and breast carcinoma.